414 related articles for article (PubMed ID: 15736974)
1. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.
Chandrashekaran IR; Yao S; Wang CC; Bansal PS; Alewood PF; Forbes BE; Wallace JC; Bach LA; Norton RS
Biochemistry; 2007 Mar; 46(11):3065-74. PubMed ID: 17305365
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization.
Kiefer MC; Schmid C; Waldvogel M; Schläpfer I; Futo E; Masiarz FR; Green K; Barr PJ; Zapf J
Growth Regul; 1993 Mar; 3(1):56-9. PubMed ID: 7683532
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
Kibbey MM; Jameson MJ; Eaton EM; Rosenzweig SA
Mol Pharmacol; 2006 Mar; 69(3):833-45. PubMed ID: 16306230
[TBL] [Abstract][Full Text] [Related]
6. Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain.
Ständker L; Braulke T; Mark S; Mostafavi H; Meyer M; Höning S; Giménez-Gallego G; Forssmann WG
Biochemistry; 2000 May; 39(17):5082-8. PubMed ID: 10819974
[TBL] [Abstract][Full Text] [Related]
7. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance.
Carrick FE; Hinds MG; McNeil KA; Wallace JC; Forbes BE; Norton RS
J Mol Endocrinol; 2005 Jun; 34(3):685-98. PubMed ID: 15956340
[TBL] [Abstract][Full Text] [Related]
8. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
[TBL] [Abstract][Full Text] [Related]
9. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.
Qin X; Byun D; Strong DD; Baylink DJ; Mohan S
J Bone Miner Res; 1999 Dec; 14(12):2079-88. PubMed ID: 10620067
[TBL] [Abstract][Full Text] [Related]
10. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit.
Twigg SM; Hardman KV; Baxter RC
Growth Horm IGF Res; 2000 Aug; 10(4):215-23. PubMed ID: 11032705
[TBL] [Abstract][Full Text] [Related]
11. Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3.
Fielder PJ; Rosenfeld RG; Graves HC; Grandbois K; Maack CA; Sawamura S; Ogawa Y; Sommer A; Cohen P
Growth Regul; 1994 Dec; 4(4):164-72. PubMed ID: 7538844
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
13. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.
Qin X; Byun D; Lau KH; Baylink DJ; Mohan S
Arch Biochem Biophys; 2000 Jul; 379(2):209-16. PubMed ID: 10898936
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
[TBL] [Abstract][Full Text] [Related]
16. C-terminal domain of insulin-like growth factor (IGF) binding protein 6: conformational exchange and its correlation with IGF-II binding.
Yao S; Headey SJ; Keizer DW; Bach LA; Norton RS
Biochemistry; 2004 Sep; 43(35):11187-95. PubMed ID: 15366928
[TBL] [Abstract][Full Text] [Related]
17. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
Headey SJ; Leeding KS; Norton RS; Bach LA
J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
[TBL] [Abstract][Full Text] [Related]
18. Characterization of truncated insulin-like growth factor-binding protein-2 in human milk.
Ho PJ; Baxter RC
Endocrinology; 1997 Sep; 138(9):3811-8. PubMed ID: 9275069
[TBL] [Abstract][Full Text] [Related]
19. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
Jansson M; Uhlen M; Nilsson B
Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
[TBL] [Abstract][Full Text] [Related]
20. Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6.
Neumann GM; Marinaro JA; Bach LA
Biochemistry; 1998 May; 37(18):6572-85. PubMed ID: 9572875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]